BEAT
HeartBeam, Inc. [BEAT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BEAT Stock Summary
Top 10 Correlated ETFs
BEAT
Top 10 Correlated Stocks
BEAT
In the News
BEAT Financial details
Company Rating
-
Market Cap
51.34M
Income
-14.62M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
15
Optionable
No
Shortable
Yes
Earnings
11 May 2024
P/E
-3.64
Forward P/E
-
PEG
0.91
P/S
-
P/B
2.81
P/C
-
P/FCF
-4.28
Quick Ratio
18.83
Current Ratio
19.12
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.94
EPS next Y
-
EPS next Q
-
EPS this Y
-54.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
15.38%
-
-
-
-
SMA20
-30%
SMA50
15.24%
SMA100
45.38%
Inst Own
-
Inst Trans
-
ROA
-73%
ROE
-140%
ROC
-0.8%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.06-3.74
52W High
-45.33%
52W Low
+64%
RSI
36.57
Rel Volume
5.71
Avg Volume
126.19K
Volume
720.13K
Perf Week
-21.15%
Perf Month
-28.7%
Perf Quarter
72.69%
Perf Half Y
28.13%
-
-
-
-
Beta
-1.224
-
-
Volatility
0.1%, 0.42%
Prev Close
-7.87%
Price
1.64
Change
-5.75%
Company Profile
- Volume Average 126.19K
- Market Capitalization 51.34M
- Employee 15
- CEO Dr. Branislav Vajdic Ph.D.
- Headquarters Santa Clara,CA,US
- IPO Date 2021-11-11
-
Website
https://www.heartbeam.com 
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
